Published in Aging Cell on October 01, 2002
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 11.43
The essence of senescence. Genes Dev (2010) 8.21
Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc (2009) 4.47
Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med (2010) 3.79
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest (2013) 3.47
Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun (2012) 2.90
Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage (2009) 2.65
Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev (2010) 2.49
Cellular senescence and its effector programs. Genes Dev (2014) 2.37
DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci (2010) 2.34
Senescence in human intervertebral discs. Eur Spine J (2006) 2.00
Cellular senescence and organismal aging. Mech Ageing Dev (2008) 1.92
NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets (2010) 1.89
Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther (2007) 1.85
Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med (2015) 1.82
Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol (2014) 1.77
Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther (2006) 1.51
Adult-onset, short-term dietary restriction reduces cell senescence in mice. Aging (Albany NY) (2010) 1.45
Effects of aging on articular cartilage homeostasis. Bone (2012) 1.40
Cellular senescence controls fibrosis in wound healing. Aging (Albany NY) (2010) 1.36
Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin Pharmacol Ther (2012) 1.25
Aging by epigenetics--a consequence of chromatin damage? Exp Cell Res (2008) 1.25
Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilage. BMC Mol Biol (2008) 1.22
Cellular senescence, ageing and disease. Age (Dordr) (2008) 1.17
Molecular links between cellular senescence, longevity and age-related diseases - a systems biology perspective. Aging (Albany NY) (2011) 1.12
Epigenetic control of aging. Antioxid Redox Signal (2010) 1.02
Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage (2015) 1.02
The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev (2013) 1.01
Caveolin-1 expression and stress-induced premature senescence in human intervertebral disc degeneration. Arthritis Res Ther (2008) 1.00
Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study. Ann Rheum Dis (2006) 1.00
Senescent cells and their secretory phenotype as targets for cancer therapy. Interdiscip Top Gerontol (2013) 1.00
Histone modifications in senescence-associated resistance to apoptosis by oxidative stress. Redox Biol (2013) 0.98
Physical activity and telomere biology: exploring the link with aging-related disease prevention. J Aging Res (2011) 0.98
Cellular Senescence - its role in cancer and the response to ionizing radiation. Genome Integr (2011) 0.98
Regulation of senescence in cancer and aging. J Aging Res (2011) 0.98
Clinical strategies and animal models for developing senolytic agents. Exp Gerontol (2014) 0.96
Senescence at a glance. J Cell Sci (2013) 0.88
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression. PLoS One (2008) 0.87
The distribution pattern of critically short telomeres in human osteoarthritic knees. Arthritis Res Ther (2012) 0.87
Selection of suitable reference genes for normalization of quantitative real-time polymerase chain reaction in human cartilage endplate of the lumbar spine. PLoS One (2014) 0.86
The emerging role of senescent cells in tissue homeostasis and pathophysiology. Pathobiol Aging Age Relat Dis (2015) 0.84
Induction of cellular senescence by secretory phospholipase A2 in human dermal fibroblasts through an ROS-mediated p53 pathway. J Gerontol A Biol Sci Med Sci (2009) 0.82
Overexpression of Sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development. Sci Rep (2015) 0.82
Hypoxia, RONS and energy metabolism in articular cartilage. Osteoarthritis Cartilage (2010) 0.80
Role of Chondrocytes in Cartilage Formation, Progression of Osteoarthritis and Cartilage Regeneration. J Dev Biol (2015) 0.78
Age-related NADPH Oxidase (arNOX) Activity Correlated with Cartilage Degradation and Bony Changes in Age-related Osteoarthritis. J Korean Med Sci (2015) 0.77
Biology and mechano-response of tendon cells: Progress overview and perspectives. J Orthop Res (2015) 0.76
Modulation of bacterial pathogenesis by oppressive aging factors: insights into host-pneumococcal interaction strategies. ISRN Inflamm (2012) 0.76
Specific premature epigenetic aging of cartilage in osteoarthritis. Aging (Albany NY) (2016) 0.76
Involvement of ERCC1 in the pathogenesis of osteoarthritis through the modulation of apoptosis and cellular senescence. J Orthop Res (2014) 0.76
Old cells, new tricks: chromatin structure in senescence. Mamm Genome (2016) 0.76
Characterisation of a divergent progenitor cell sub-populations in human osteoarthritic cartilage: the role of telomere erosion and replicative senescence. Sci Rep (2017) 0.76
Osteoarthritis and telomere shortening. J Appl Genet (2014) 0.75
Intraarticular Injection of Allogenic Mesenchymal Stem Cells has a Protective Role for the Osteoarthritis. Chin Med J (Engl) (2015) 0.75
Changes in the Transcriptome of Human Astrocytes Accompanying Oxidative Stress-Induced Senescence. Front Aging Neurosci (2016) 0.75
Gaps in Aging Research as it Applies to Rheumatologic Clinical Care. Clin Geriatr Med (2016) 0.75
Chondroprotective Effects of Ginsenoside Rg1 in Human Osteoarthritis Chondrocytes and a Rat Model of Anterior Cruciate Ligament Transection. Nutrients (2017) 0.75
Lectin-like, oxidized low-density lipoprotein receptor-1-deficient mice show resistance to age-related knee osteoarthritis. Eur J Histochem (2017) 0.75
Cellular senescence in osteoarthritis pathology. Aging Cell (2017) 0.75
Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice. Aging (Albany NY) (2016) 0.75
Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci (2002) 4.23
The ADAMTS metalloproteinases. Biochem J (2005) 3.95
Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum (2004) 3.00
The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol (2007) 2.49
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum (2011) 1.92
MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest (2011) 1.77
Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res (2005) 1.77
Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. Arthritis Rheum (2013) 1.74
Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci (2002) 1.69
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain (2003) 1.67
Structure, fluctuation and magnitude of a natural grassland soil metagenome. ISME J (2012) 1.66
Osteoarthritis in patients with anterior cruciate ligament rupture: a review of risk factors. Knee (2008) 1.64
Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer (2005) 1.63
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res (2008) 1.57
Accessing the soil metagenome for studies of microbial diversity. Appl Environ Microbiol (2010) 1.53
Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther (2006) 1.51
Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res (2003) 1.50
Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. FEBS Lett (2004) 1.48
Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum (2006) 1.48
Distribution of environmental mycobacteria in Karonga District, northern Malawi. Appl Environ Microbiol (2006) 1.47
Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med (2005) 1.47
Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res (2004) 1.46
The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J Biol Chem (2003) 1.45
Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther (2005) 1.37
An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci (2003) 1.34
Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol (2004) 1.32
Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology (2005) 1.31
Clinical and radiological outcomes of fixed- versus mobile-bearing total knee replacement: a meta-analysis. Knee Surg Sports Traumatol Arthrosc (2009) 1.30
Matrix metalloproteinases: protective roles in cancer. J Cell Mol Med (2011) 1.29
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res (2009) 1.28
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis (2010) 1.25
TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2009) 1.24
Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score. Oncol Rep (2008) 1.24
Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res (2010) 1.22
Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res (2007) 1.21
Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid. J Biol Chem (2003) 1.21
Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. J Immunol (2009) 1.20
Determinants of human B cell migration across brain endothelial cells. J Immunol (2003) 1.19
Fungal molecular diagnostics: a mini review. J Appl Genet (2004) 1.18
An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J (2005) 1.18
Soil pH determines microbial diversity and composition in the park grass experiment. Microb Ecol (2014) 1.18
Acute patellar dislocation in children and adolescents: a randomized clinical trial. J Bone Joint Surg Am (2008) 1.16
Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue. Eur J Oral Sci (2003) 1.16
Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res (2006) 1.16
Co-induction of glutathione-S-transferases and multidrug resistance associated protein by xenobiotics in wheat. Pest Manag Sci (2003) 1.14
Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage. Am J Pathol (2009) 1.10
The clinical and radiological outcomes of hip resurfacing versus total hip arthroplasty: a meta-analysis and systematic review. Acta Orthop (2010) 1.09
Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level. RNA (2010) 1.09
Operative versus non-operative management of patellar dislocation. A meta-analysis. Knee Surg Sports Traumatol Arthrosc (2011) 1.09
The diagnostic accuracy of acetabular labral tears using magnetic resonance imaging and magnetic resonance arthrography: a meta-analysis. Eur Radiol (2010) 1.08
Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br J Pharmacol (2002) 1.08
Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis. Arthritis Rheum (2010) 1.08
The use of real-time PCR and species-specific primers for the identification and monitoring of Paecilomyces lilacinus. FEMS Microbiol Ecol (2005) 1.07
Metalloproteinases and their inhibitors in angiogenesis. Expert Rev Mol Med (2003) 1.06
Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. Carcinogenesis (2005) 1.06
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin Cancer Res (2013) 1.06
The reliability and validity of radiological assessment for patellar instability. A systematic review and meta-analysis. Skeletal Radiol (2010) 1.05
Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks. J Immunol (2010) 1.05
Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res (2006) 1.04
Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. J Biol Chem (2001) 1.04
Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia (2007) 1.03
Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res (2002) 1.02
HDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes. Matrix Biol (2010) 1.01
Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene. Biochem J (2002) 1.00
The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis. Front Biosci (Landmark Ed) (2011) 0.99
Insulin-like growth factor-II regulates PTEN expression in the mammary gland. J Biol Chem (2003) 0.98
Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice. J Biol Chem (2008) 0.98
Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo. Arthritis Rheum (2013) 0.97
Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. Differentiation (2002) 0.97
Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis Res Ther (2006) 0.97
Monocyte-astrocyte networks regulate matrix metalloproteinase gene expression and secretion in central nervous system tuberculosis in vitro and in vivo. J Immunol (2007) 0.96
Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Mol Cancer Res (2008) 0.96
Review: the role of microRNAs in osteoarthritis and chondrogenesis. Arthritis Rheum (2013) 0.96
Imaging the femoral sulcus with ultrasound, CT, and MRI: reliability and generalizability in patients with patellar instability. Skeletal Radiol (2009) 0.96
Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition. Biochim Biophys Acta (2009) 0.96
Accuracy of clinical diagnosis in patients undergoing knee arthroscopy. Int Orthop (2009) 0.96
Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time RT-PCRs. Anal Biochem (2002) 0.95
Reversible transdifferentiation of blood vascular endothelial cells to a lymphatic-like phenotype in vitro. J Cell Sci (2010) 0.95
ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. Int J Cancer (2006) 0.95